RICHMOND, Virginia — FUJIFILM Wako Chemicals U.S.A., Corporation today announces the launch of a ready-to-use small molecule cocktail comprising of Chroman 1, Emricasan, Polyamines, Trans-ISRIB (CEPT Cocktail), a chemical platform for stress-free cell culture and superior survival of induced pluripotent stem cells (iPSCs). CEPT Cocktail is intended for commercial research-use of iPSC applications including disease […]

SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura., “Astellas”), by which Astellas will license a suite of Twist’s VHH antibody libraries to be […]

SAN DIEGO, CA – Element Biosciences, Inc.— developer of an innovative DNA sequencing platform that is disrupting the genomics industry — has signed distribution agreements with companies based in Israel, South Korea, Australia, and the United Arab Emirates to bring its AVITI System to more customers around the world. The strong global demand for AVITI […]

The acquisition extends Excelra’s AI, machine learning, and data science capabilities, and enhances its platform and service portfolio. BOSTON — Gent, Belgium & Hyderabad, India: Excelra, a leading life science data and digital solutions provider, has acquired BISC Global, a bioinformatics and data analytics consulting company with offices across Europe and the USA. The acquisition creates […]

Combination of PacBio’s HiFi Sequencing Capabilities and Form Bio’s Computational Platform and Solutions Helps Biopharma and Academic Researchers Innovate and Accelerates Gene Therapy Product Development DALLAS – Form Bio, the provider of advanced computational life sciences technology, today announced it has joined the PacBio Compatible program. As part of the program, the Form Bio platform […]

Tromsø, Norway – ArcticZymes Technologies ASA (OSE:AZT) announces the launch of ArcticZymes Proteinase HQ to the B2B market. Following up on earlier press-releases (9th Dec 2022) ArcticZymes is pleased to launch the latest member in our Proteinase product portfolio: ArcticZymes Proteinase HQ. This product is the ‘bioprocessing grade’ version of our existing successful ArcticZymes Proteinase and […]

SOPHiA GENETICS  supports The University of Maryland Medical Center to advance their rare disease research BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the University of Maryland Medical Center (UMMC) is using SOPHiA GENETICS technology to enhance […]

DALLAS  – Almaden Genomics has updated its g.nome™ platform to integrate with Jupyter Notebook, an open-source web-based environment that is commonly used for collaborative research. The software combination will further enable scientists and bioinformaticians to accelerate genomic discovery by leveraging g.nome’s cloud-native and intuitive NGS workflow builder with a widely used data visualization tool. “We […]

Single, standalone, plug-and-play genomics appliance from long read and short read sequencers’ FASTQ data, to prioritized, causal variants report SAN JOSE, CA. USA: OmniTier Inc, a leader in on-premise genomics analysis products, today launched the industry’s first on-premise, standalone appliance for both human genomic data analysis (secondary analysis) and biomedical data interpretation (tertiary analysis), called CompStor […]

TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced the achievement of three significant drug discovery business milestones in the first quarter of 2023. As reported in January 2023, HTG filed a patent application on December 28, 2022, which included claims directed toward specific compounds, […]